Speaker Profile
Ph.D., Senior Research Scientist, Watchmaker Genomics
Biography
After a short-lived career as a coffee analytical chemist, Craig graduated with a PhD in biochemistry and molecular biology from Colorado State University in 2021 and immediately joined Watchmaker Genomics as a scientist in enzyme development. He has since transitioned into applications development, focusing mainly on new and existing epigenetics-related projects.
Talk
TBD
TBD
Clinical Dx Showcase:
Watchmaker Genomics
Watchmaker Genomics specializes in advanced enzymology to develop precision tools for life sciences. We utilize a platform that integrates computational biology, protein engineering, and enzyme production to create high-performance tools for next-generation sequencing and advanced applications, including rare variant detection, ctDNA analysis, transcriptomics, and epigenetics.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
